Anavex Life Sciences Q2 EPS $(0.06) Beats $(0.08) Estimate

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.08) by 25 percent. This is a 53.85 percent increase over losses of $(0.13) per share from the same period last year.